4Chau I,Norman AR,Cunningham D,et al.Multivariate prognostic factor analysis in locally advanced and metastatic esophagogastric cancer.Pooled analysis from three multicenter,randomized,controlled trials using individual patient data[J].J Clin Oncol,2004,22(12):2 395.
5Mathews MB,Bernstein KM,Franza BR,et al.identity of the proliferating cell nuclear antigen and cyclin[J].Nature,1984,16(9):303.
6Liu B,Ying J,Luo C. S-1 combined with oxaliplatin as first line chemotherapy for chinese advanced gastric cancer patients[J].Hepato-Gastroenterology,2012,(114):649-653.
7Koizumi W,Takiuchi H,Yamada Y. Phase Ⅱ study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study)[J].Annals of Oncology,2010,(05):1001-1005.
8Kim JH,Oh SY,Kwon HC. Phase Ⅱ study of gemcitabine plus cisplatin in patients with anthracycline-and taxanepretreated metastatic breast cancer[J].Cancer Res Treat,2008,(03):101-105.
9Lee JL,Kang HJ,Kang YK. Phase Ⅰ/Ⅱ study of 3-week combination of S-1 and cisplatin chemotherapy for metastatic or recurrent gastric cancer[J].Cancer Chemotherapy and Pharmacology,2008,(05):837-845.
